WBB Securities Upgrades ViroPharma to Strong Buy

by Juan Lopez, Benzinga Staff Writer

December 15, 2011 7:44 AM | 7 seconds read | Make a Comment

WBB Securities has upgraded ViroPharma

VPHM

to Strong Buy and has raised the price target to $31.25.

Posted In: Upgrades Price Target Pre-Market Outlook Analyst Ratings WBB Securities

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.